Moreover, cytokines trigger organ injury, and increased levels of TNF-α are thought to improve adverse clinical outcomes in kidney disease patients [16]. Furthermore, polymorphisms in the TNF-α promotor region are known to affect transcriptional activity and show adverse clinical outcomes in critically ill patients [17-19]. This evidence concerns the gene TNF and kidney disorder.